News Celgene baffles market with Crohn's drug data Analysts left guessing from snippet of early phase data.
News Shire buys rights to Pfizer gastrointestinal drug Shire has bought rights to PF-00547659 for an undisclosed sum.
News Biosimilar switching not suitable for all patients Antibodies against originator will also target biosimilar.
News Neuralink gets okay for its first international trial Elon Musk's brain-computer interface (BCI) company Neuralink has been given the green light to test its device in tetraplegic patients in Canada
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
